Showing results (61-70 of 201) with videos related to
Sort By:
Pageof 21
Scandinavian Journal of Infectious Diseases|January 1, 1988
In vitro selection of Escherichia coli mutants with decreased susceptibility to norfloxacinA Forsgren, A C StribyInfection and Immunity|August 1, 1974
Influence of the alternate complement pathway in opsonization of several bacterial speciesA Forsgren, P G QuieEuropean Journal of Clinical Microbiology|December 1, 1985
Effect of ciprofloxacin on phagocytosisA Forsgren, P I BergkvistScandinavian Journal of Rheumatology|September 23, 2011
Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestationsA Scheja, M Wildt, D M Wuttge, et al.British Journal of Rheumatology|January 1, 1993
Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse diseaseA Scheja, G Hellmer, F A Wollheim, et al.Scandinavian Journal of Rheumatology|February 14, 2009
Renal function is mostly preserved in patients with systemic sclerosisA Scheja, I Bartosik, D M Wuttge, et al.The Journal of Rheumatology|April 1, 1994
Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosisA Scheja, J Eskilsson, A Akesson, et al.Annals of the Rheumatic Diseases|October 1, 1993
Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung complianceA Scheja, A Akesson, P Wollmer, et al.Arthritis and Rheumatism|May 1, 1994
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamideA Akesson, A Scheja, A Lundin, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1980
Effects of antithyroid drugs on lymphocyte function in vitroB Hallengren, A Forsgren, A MelanderPageof 21